The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Building a model to predict the risk of multiple severe neurotoxicities in cancer survivors after cisplatin treatment.
 
Swetha Nakshatri
Patents, Royalties, Other Intellectual Property - Bifidobacterium longum subsp. infantis Bg40721_2D9_SN_2018 for the treatment and/or prevention of acute malnutrition in infants and young children. (This is pending).; Cancer detection utilizing normal tissue adjacent to breast tumors with genetic ancestry mapping (filed, not received) (I); Diagnostic Methods for detection of cancer (US patent #9,200,325) - 2015 (I); FOXA1 in prediction of efficacy of hormonal therapy in breast cancer (PCT/US2008/52397-patent pending)- Licensed to Clarient, Inc (I); IU hMuSC cell line (in process) - 2020 (I); Methods for early detection of breast cancer (63/074101) filed - 2020 (I); Patent Awarded – Use of Parthenolide to Inhibit Cancer (6890946) issued on 5/10/2005- co-founded Leuchemix, Inc (currently relinquished the company stakes) (I); Prognostic Indicator for Metastatic Prostate Cancer (patent issued on 4/02/19 US patent 10,247,732 B2) (I)
 
Megan Shuey
No Relationships to Disclose
 
Mohammad Shahbazi
Stock and Other Ownership Interests - Pfizer
 
Matthew Trendowski
No Relationships to Disclose
 
Paul C. Dinh
No Relationships to Disclose
 
Darren R. Feldman
Consulting or Advisory Role - Cigna
Research Funding - Astellas Pharma; Decibel Therapeutics (Inst); Seagen
Other Relationship - UpToDate
 
Robert James Hamilton
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen
Research Funding - Bayer; Janssen
Travel, Accommodations, Expenses - Janssen
 
David J. Vaughn
Research Funding - Astellas Pharma (Inst); Merck Sharp & Dohme (Inst)
 
Chunkit Fung
Consulting or Advisory Role - Exelixis; Novartis; Novartis
Research Funding - Astellas Pharma (Inst)
 
Christian K. Kollmannsberger
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen Oncology; Merck; Merck KGaA; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Gilead Sciences; Ipsen; Janssen; Merck; Merck KGaA; Pfizer
Travel, Accommodations, Expenses - Ipsen; Pfizer
 
Lawrence Einhorn
Stock and Other Ownership Interests - Amgen
 
Robert D. Frisina
Patents, Royalties, Other Intellectual Property - Patent Awarded for a new drug combination (hormone, anti-inflammatory) to treat age-related hearing loss. (Inst); Patent awarded for new neural stimulation technique involving laser light and gold nanoparticles (Inst)
 
Lois B. Travis
No Relationships to Disclose
 
Mary Eileen Dolan
No Relationships to Disclose
 
Nancy Cox
No Relationships to Disclose